Loading icon
Press enter or spacebar to select a desired language.
Research
Press enter or spacebar to select a desired language.

PubMed COVID-19 Clinical Care

21951 - 21960 of 44979 results found

In-silico modeling of the interplay between APOE4, NLRP3, and ACE2-SPIKE complex in neurodegeneration between Alzheimer and SARS-CoV: implications for understanding pathogenesis and developing therapeutic strategies

Date
Tuesday, August 29, 2023 - 4:00 AM
Description
The multifaceted interplay between neurodegenerative pathologies, including Alzheimer's disease (AD), and the highly virulent severe acute respiratory syndrome coronavirus (SARS-CoV), is implicated in various conditions. AD and SARS-CoV pathogenesis

China's carbon emissions peaking pathway in the post-COVID-19 era

Date
Tuesday, August 29, 2023 - 4:00 AM
Description
Several countries have weakened the carbon emission objectives to immediately revive the economy in the post-COVID-19 era. Therefore, it is a challenge worth addressing to readjust the economic development and carbon emissions after the COVID-19

Identifying the Toxidrome of Ivermectin Toxicity

Date
Tuesday, August 29, 2023 - 4:00 AM
Description
Ivermectin is an antiparasitic drug that has been used as an alternative for prophylaxis and treatment of COVID-19 infection. The adverse effects from supratherapeutic doses of ivermectin can include non-neurological and neurological symptoms. In

Geographic Disparities in Access to Cancer Clinical Trials in Canada

Date
Tuesday, August 29, 2023 - 4:00 AM
Description
CONCLUSIONS: Access to clinical trials in Canada is not equitably distributed, with geographical and primary tumor site disparities. Moreover, access to cancer clinical trials has been negatively impacted during the time of the COVID-19 pandemic.